Estimated reading time: 0 minutes, 29 seconds
Johnson & Johnson, along with other drug companies facing “thousands” of lawsuits related to the U.S. opioid epidemic are concerned settlement talks will be jeopardized if the plaintiffs’ lawyers are permitted to “assess a fee payment worth billions of dollars.” So reports Reuters.
McKesson Corp and Teva Pharmaceutical Industries Ltd joined a request to reject a 7% fee levied against any settlements. A consolidated list of lawsuits alleges the crisis led to the deaths of 400,000 people in the U.S. since 1999. A trial is expected to begin Friday, March 20 in New York.